Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Maixin Company Participates in the 17th National Symposium on Diagnostic Pathology and Advances in Pathology

Continue reading
06 2 月

Immunohistochemical Differentiation of Carcinoma, Mesothelioma, and Reactive Mesothelial Cells

Continue reading
06 2 月

Notice from the Organizing Committee of the Lecture Series by Professor Chen Guozhang and Professor Zhuo Hua and the Continuing Education Seminar of the Department of Pathology, Zhongshan Hospital Affiliated to Fudan University (First Round Notice)

Continue reading
06 2 月

Policy Boost | Government Subsidized Medical Equipment Upgrade Projects, Maxim’s Comprehensive and Integrated Pathology Solutions Facilitate New Developments in Pathology Discipline

Continue reading
06 2 月

Typhoon Rages, Pathologists Show Deep Affection and Great Love — A Report on the Successful Conclusion of the CCP’s Fourth Term Election Conference in Fuzhou

Continue reading
29 1 月

Establishing a typical immunohistochemistry laboratory requires the following equipment:

Continue reading
28 1 月

Maixin Company Profile

Continue reading
28 1 月

Fuzhou Maixin Biotechnology Development Co., Ltd. – Announcement of Winning Bid for Production Management and Quality Inspection Management Software Project

Continue reading
28 1 月

Fuzhou Maixin Biotechnology Development Co., Ltd. Tender Announcement

Continue reading
28 1 月

Table 8. Immunohistochemical Differentiation Chart for Primary Malignant Epithelial Ovarian Tumors

Continue reading
  • «
  • ‹
  • 47
  • 48
  • 49
  • 50
  • ›

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar